Literature DB >> 33651797

Helminth species specific expansion and increased TNF-alpha production of non-classical monocytes during active tuberculosis.

Gezahegn Bewket1, Amare Kiflie1, Ebba Abate1,2, Olle Stendahl3, Thomas Schön3,4, Robert Blomgran3.   

Abstract

Both Mycobacterium tuberculosis infection and helminths may affect innate immune mechanisms such as differential effects on monocytes towards the non-classical and intermediate subsets that favor bacterial persistence. Our aim, was to investigate helminth species specific effects on the frequency and functional activity of monocyte subsets in patients with active tuberculosis and healthy subjects. HIV-negative patients with active pulmonary tuberculosis (PTB) and community controls (CCs) in Gondar, Ethiopia were screened for helminth infection by stool microscopy. Flow cytometric analysis of peripheral blood mononuclear cells (PBMCs) and ex vivo stimulation with purified protein derivative (PPD) and helminth antigens were used to characterize the distribution of monocyte subsets and their function. A total of 74 PTB patients and 57 CCs with and without helminth infection were included. Non-classical monocytes were increased in PTB patients with Ascaris and hookworm infection but not in Schistosoma-infected patients. Ascaris had the strongest effect in increasing the frequency of non-classical monocytes in both PTB patients and CCs, whereas PTB without helminth infection did not affect the frequency of monocyte subsets. There was a helminth specific increase in the frequency of TNF-α producing non-classical monocytes in hookworm infected PTB patients, both with and without PPD-stimulation. Low-to-intermediate TB disease severity associated with increased frequency of non-classical monocytes only for helminth-positive PTB patients, and the frequency of TNF-α producing monocytes were significantly higher in intermediate and non-classical monocytes of helminth positive PTB patients with an intermediate disease score. Helminth infection affected the frequency of monocyte subsets and function both in TB patients and controls which was helminth species dependent in TB patients. The clinical role of this potential immunomodulatory effect needs further study and may affect the response and protection to tuberculosis in areas where helminth infections are endemic.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33651797      PMCID: PMC7954301          DOI: 10.1371/journal.pntd.0009194

Source DB:  PubMed          Journal:  PLoS Negl Trop Dis        ISSN: 1935-2727


  49 in total

1.  Intestinal helminth co-infection has a negative impact on both anti-Mycobacterium tuberculosis immunity and clinical response to tuberculosis therapy.

Authors:  T Resende Co; C S Hirsch; Z Toossi; R Dietze; R Ribeiro-Rodrigues
Journal:  Clin Exp Immunol       Date:  2007-01       Impact factor: 4.330

2.  SuperSAGE evidence for CD14++CD16+ monocytes as a third monocyte subset.

Authors:  Adam M Zawada; Kyrill S Rogacev; Björn Rotter; Peter Winter; Rolf-R Marell; Danilo Fliser; Gunnar H Heine
Journal:  Blood       Date:  2011-07-29       Impact factor: 22.113

3.  Ascaris Suum Infection Downregulates Inflammatory Pathways in the Pig Intestine In Vivo and in Human Dendritic Cells In Vitro.

Authors:  Helene L E Midttun; Nathalie Acevedo; Per Skallerup; Sara Almeida; Kerstin Skovgaard; Lars Andresen; Søren Skov; Luis Caraballo; Irma van Die; Claus B Jørgensen; Merete Fredholm; Stig M Thamsborg; Peter Nejsum; Andrew R Williams
Journal:  J Infect Dis       Date:  2018-01-04       Impact factor: 5.226

Review 4.  'Coinfection-helminthes and tuberculosis'.

Authors:  Wasiulla Rafi; Rodrigo Ribeiro-Rodrigues; Jerrold J Ellner; Padmini Salgame
Journal:  Curr Opin HIV AIDS       Date:  2012-05       Impact factor: 4.283

5.  Effects of albendazole on the clinical outcome and immunological responses in helminth co-infected tuberculosis patients: a double blind randomised clinical trial.

Authors:  E Abate; D Elias; A Getachew; S Alemu; E Diro; S Britton; A Aseffa; O Stendahl; T Schön
Journal:  Int J Parasitol       Date:  2014-12-05       Impact factor: 3.981

Review 6.  Helminth-Tuberculosis Co-infection: An Immunologic Perspective.

Authors:  Subash Babu; Thomas B Nutman
Journal:  Trends Immunol       Date:  2016-08-05       Impact factor: 16.687

7.  CD14, CD16 and HLA-DR reliably identifies human monocytes and their subsets in the context of pathologically reduced HLA-DR expression by CD14(hi) /CD16(neg) monocytes: Expansion of CD14(hi) /CD16(pos) and contraction of CD14(lo) /CD16(pos) monocytes in acute liver failure.

Authors:  Robin Daniel Abeles; Mark J McPhail; David Sowter; Charalambos G Antoniades; Nikhil Vergis; Godhev K Manakkat Vijay; Emmanuel Xystrakis; Wafa Khamri; Debbie L Shawcross; Yun Ma; Julia A Wendon; Diego Vergani
Journal:  Cytometry A       Date:  2012-07-26       Impact factor: 4.355

8.  Intensity of intestinal infection with multiple worm species is related to regulatory cytokine output and immune hyporesponsiveness.

Authors:  Joseph D Turner; Joseph A Jackson; Helen Faulkner; Jerzy Behnke; Kathryn J Else; Joseph Kamgno; Michel Boussinesq; Janette E Bradley
Journal:  J Infect Dis       Date:  2008-04-15       Impact factor: 5.226

9.  Differential expression and predictive value of monocyte scavenger receptor CD163 in populations with different tuberculosis infection statuses.

Authors:  Qianqian Liu; Qinfang Ou; Huaxin Chen; Yan Gao; Yuanyuan Liu; Yuzhen Xu; Qiaoling Ruan; Wenhong Zhang; Lingyun Shao
Journal:  BMC Infect Dis       Date:  2019-11-28       Impact factor: 3.090

Review 10.  Monocyte Subsets: Phenotypes and Function in Tuberculosis Infection.

Authors:  Pavithra Sampath; Kadar Moideen; Uma Devi Ranganathan; Ramalingam Bethunaickan
Journal:  Front Immunol       Date:  2018-07-30       Impact factor: 7.561

View more
  1 in total

1.  Helminth species dependent effects on Th1 and Th17 cytokines in active tuberculosis patients and healthy community controls.

Authors:  Gezahegn Bewket; Amare Kiflie; Fitsumbrhan Tajebe; Ebba Abate; Thomas Schön; Robert Blomgran
Journal:  PLoS Negl Trop Dis       Date:  2022-08-17
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.